glp 1 drugs and pancreatitis Risk of pancreatic cancer associated with GLP-1 receptor agonist therapy Do GLP-1 drugs cause pancreatitis?
Description
[(accessed on 21 March 2025)]
Disease burden and epidemiological trends of chronic kidney disease at the global, regional, national levels from 1990 to 2019
Krajnc N, Itariu B, Macher S, et al
Pharmacokinetics and pharmacodynamiceffects of the oral DPP-4 inhibitor sitagliptin in middle-aged obese subjects
GLP-1 agonist medications, which target the GLP-1 receptor to regulate insulin, glucagon, and appetite, offer a promising therapeutic approach to these health challenges
The confidence intervals representing the relative risk crossed 1.0 for each trial
